BPTH CIK: 1133818

Bio-Path Holdings Inc.

  • United States
  • Healthcare
  • Biotechnology
Metrics score locked — part of Premium
FY20
FY21
FY22
FY23
FY24
FY20 – FY24
(positive)
millions USD
FY20:
–
FY21:
–
FY22:
–
FY23:
–
FY24:
–
(positive)
Change from FY20 to FY24
millions USD
FY20:
−10.9
FY21:
−10.4
FY22:
−13.9
FY23:
−15.8
FY24:
−12.0
(positive)
Change from FY20 to FY24
millions USD
FY20:
−10.8
FY21:
−10.3
FY22:
−13.7
FY23:
−15.4
FY24:
−13.9
(positive)
Change from FY20 to FY24
millions USD
FY20:
−10.9
FY21:
−10.4
FY22:
−13.9
FY23:
−16.1
FY24:
−9.89
(positive)
Change from FY20 to FY24
millions USD
FY20:
−10.9
FY21:
−10.4
FY22:
−13.9
FY23:
−16.1
FY24:
−9.89

All amounts in millions USD Data sources:SEC EDGARTwelve Data